Josh Gottheimer has no news peg today. Zero stories in the last 24 hours. The Google News trending signal is ambient, the kind of slow-burn attention that follows a member who keeps showing up in conversations about which Democrats are one bad headline away from a primary. What Blind Trust does have is his financial record: 39 disclosed stock trades in the last 90 days, a Micron Technology purchase that posted 48% alpha in 30 days, and a seat on the House Financial Services Committee's digital assets and capital markets subcommittees. When you lay those facts next to each other, the public record handles the rest.
The Volume
Thirty-nine trades in 90 days works out to roughly one trade every 2.3 days. For a member of Congress, that's a pace that keeps the disclosure staff busy.
The recent batch is almost entirely sales. Between June 1 and June 17 alone, Gottheimer filed seven separate sale disclosures: Nintendo ADRs, Insmed, Agree Realty, Alibaba, Booking Holdings, Nestle, and Novozymes. All in the $1,001–$15,000 band. All on the same day, June 1, except for the Insmed sale on June 10 and the Nintendo exit on June 17.
Before that, May 27 brought two Abbott Laboratories sales, also both in the $1,001–$15,000 range. The disclosure system recorded them separately, which happens when a trade gets split across accounts or filed twice. Either way: Abbott, twice, same day, same range.
You can review the full disclosure record on Blind Trust. It's a lot of line items for someone who represents a New Jersey swing district and sits on two financial oversight subcommittees.
The MU Trade Is the One That Gets Attention
On May 21, Gottheimer filed two purchases of Micron Technology. Same date, same $1,001–$15,000 range, logged separately. The 30-day alpha on those buys came in at 48.0% against the S&P 500. Forty-eight percent in a month.
The trade alpha record flags these with a "Technology" committee overlap. Gottheimer sits on the House Financial Services subcommittee covering Digital Assets, Financial Technology, and Artificial Intelligence. Micron is a semiconductor company whose business intersects directly with AI infrastructure buildout. The overlap is real, not incidental.
A high-alpha trade is not a confession. Markets move, chips were hot in May, and plenty of retail investors caught that same run. But Gottheimer's committee assignment is Financial Services, not Agriculture. When a member who oversees digital assets policy buys a leading AI-adjacent semiconductor two weeks before it pops 48%, the filing is worth reading twice.
The committee overlap list also includes two Microsoft purchases from March 25, one in the $50,000–$100,000 range and one in the $500,000–$1,000,000 range. Those posted 8.4% alpha in 30 days. Both filed the same day. Microsoft's AI and cloud division sits squarely in the territory Gottheimer's subcommittee is supposed to be watching.
Members are required to disclose. They are not required to divest, recuse, abstain, or look up from their phones. That's the rule.
The Full Scorecard
Blind Trust has scored 152 of Gottheimer's trades against the S&P 500. The record: 64 positive, 88 negative. A 42% win rate. Not a trading savant, and not someone obviously printing money on private information — just a member of Congress with a brokerage account that stays active and a results column that skews red more than green.
The best single trade in the scored sample is the Micron buy at +48%. The worst three: a sale of Tractor Supply that posted -38.1% alpha 30 days later (sold it, then it ran), a sale of Phreesia at -27.2%, and a sale of Betware at -22.3%. Selling something that then outpaces the index by 38 points is an expensive month.
Mean 30-day alpha across all 152 scored trades: +0.5%. Statistically indistinguishable from random. The committee-overlap trades are the ones Blind Trust has flagged for a reason.
The Votes
Gottheimer's recent vote sheet includes the Main Street Capital Access Act on July 21, where he voted Yea on a bill that passed. That bill sits in Financial Services territory — his committee. A yes on capital markets access legislation from a capital markets subcommittee member is not a headline, but it's a data point.
He voted Nay on the Protecting Privacy in Purchases Act on July 14. The bill passed anyway. Privacy-in-purchases legislation touches payment systems and financial data, which overlaps with the Digital Assets and Financial Technology subcommittee he sits on. He voted against it.
The National Defense Authorization Act votes from July 22 are less his lane. He voted Nay on final NDAA passage, putting him with most House Democrats. He voted Yea on an amendment involving investor access to defense-related investments, which failed. The NDAA is not a Financial Services bill; the committee overlap angle doesn't apply there.
There are no vote-trade overlaps flagged in the current dataset. The record doesn't show a trade dropping the day before a relevant committee vote. What it shows is sustained trading volume from a member with a front-row seat on capital markets regulation.
Why He's Trending Without a Story
Gottheimer has a specific political profile that keeps his name in circulation even when nothing has happened. He's a founding member of the Problem Solvers Caucus, a regular friction point for Democratic leadership, and a member from NJ-5 who has consistently outrun his district's partisan lean. The social buzz Blind Trust captured this week runs in that direction: posts lumping him in with Democrats perceived as ideological wildcards or as too close to certain foreign policy positions.
None of that is financial disclosure data. Blind Trust covers the financial record. The political positioning is a separate article.
What the financial record shows: a member who trades frequently, holds positions in sectors his subcommittees oversee, carries a 42% win rate across 152 scored trades, and posted a 48% single-trade return on a chip stock with direct AI exposure in May 2026. The worst single-trade outcome in the sample was selling Tractor Supply before it ran 38 points past the index.
The full picture at Blind Trust's Gottheimer page runs deeper than any single trade. The volume over 90 days, the committee assignments, the vote history — it's all in the public record. Whether you find it interesting likely depends on how you feel about the phrase "Financial Services subcommittee member" appearing next to "48% alpha on semiconductor purchase."
The receipts are public. Make of them what you make of them.